Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
13.18
+0.45 (3.53%)
At close: Oct 8, 2026, 4:00 PM EDT
13.07
-0.11 (-0.83%)
After-hours: Oct 8, 2026, 7:30 PM EDT
Contineum Therapeutics Employees
Contineum Therapeutics had 51 employees as of December 31, 2025. The number of employees increased by 10 or 24.39% compared to the previous year. That makes Contineum Therapeutics the 34,753rd largest employer in the world and 4,654th in the United States.
Employees
51
Change (1Y)
10
Growth (1Y)
24.39%
Revenue / Employee
n/a
Profits / Employee
-$1,128,588
Market Cap
495.85M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 51 | 10 | 24.39% |
| Dec 31, 2024 | 41 | 10 | 32.26% |
| Dec 31, 2023 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| REGENXBIO | 371 |
| Arvinas | 246 |
| ProKidney | 231 |
| Puma Biotechnology | 179 |
| Allogene Therapeutics | 152 |
| Aclaris Therapeutics | 73 |
| Rezolute | 58 |
CTNM News
- 8 days ago - Jones sees greater room for Contineum’s PIPE-791 to differentiate - TheFly
- 9 days ago - Contineum Therapeutics Inc trading resumes - TheFly
- 9 days ago - Contineum Therapeutics Inc trading halted, volatility trading pause - TheFly
- 11 days ago - Contineum price target lowered to $17 from $18 at Morgan Stanley - TheFly
- 14 days ago - Contineum resumed at Early-Stage Biotech at Goldman Sachs - TheFly
- 23 days ago - Contineum Therapeutics Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 23 days ago - Contineum price target lowered to $24 from $26 at Jones - TheFly
- 23 days ago - Contineum price target lowered to $19 from $20 at Baird - TheFly